According to Straits Research, the global cannabis testing services market size was valued at $2.7 billion in 2025 and is projected to grow from $3.17 billion in 2026 to $11.36 billion by 2034, registering a CAGR of 17.32% during the forecast period 2026–2034. The cannabis testing services market is segmented based on service, end use, and region. Some of the insights provided in the report are highlighted below: The potency testing segment dominated the market with the largest share of 26.89% in 2025. North America is expected to lead the cannabis testing services market, supported by legalized recreational and medical cannabis and strong presence of accredited third-party testing laboratories. Labs are shifting to third-party proficiency testing and inter-laboratory comparisons in response to intensified regulatory scrutiny and the need for consistent, reliable results. The UK market is driven by the legalization of specialist medical cannabis prescriptions and relies on imported EU-GMP certified cannabis products. Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings. The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market. Market Segments By Service Potency Testing Terpene Profiling Heavy Metal Testing Pesticide Screening Microscopy Testing Residual Solvent Screening Others By End Use Cannabis Cultivators/Growers Cannabis Drug Manufacturers Others (Research Institutes & Labs) By Region North America Europe Asia Pacific Middle East & Africa Latin America